Number 2 Feibi Recipe Reduces PM2.5-Induced Lung Injury in Rats
Air pollution is the main cause of respiratory diseases. Fine particulates with the diameter below 2.5 μm can get into the alveoli and then enter the blood circulation through the lung tissue ventilation function and cause multiple systemic diseases especially the respiratory diseases. This study investigated the pathological mechanism of the lungs injury in rats induced by PM2.5 and the effect and mechanism of the Chinese herbal medicine number 2 Feibi Recipe (number 2 FBR) on lungs injury. In this experiment, Wistar rats were used. Lungs injury was induced by PM2.5. Number 2 FBR was used to treat the rats. The result showed that number 2 FBR could improve the lung injury in the rats. Meanwhile, it significantly reduced pathological response and inflammatory mediators including interleukin-6 (IL-6), interleukin-13 (IL-13), interleukin-17 (IL17), monocyte chemotactic protein-1 (MCP-1), and transforming growth factor-α (TNF-α) and upregulated glutathione peroxidase (GSH-Px) in the PM2.5 induced lung injury in the rats. Collectively, number 2 FBR appears to attenuate the lungs injury in rats induced by PM2.5..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2018 |
|---|---|
| Enthalten in: |
Evidence-Based Complementary and Alternative Medicine - (2018) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhaoheng Liu [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1155/2018/3674145 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ048734160 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ048734160 | ||
| 003 | DE-627 | ||
| 005 | 20230227160107.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1155/2018/3674145 |2 doi | |
| 035 | |a (DE-627)DOAJ048734160 | ||
| 035 | |a (DE-599)DOAJ23c4c033745f474d93154fcc030d8464 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RZ201-999 | |
| 100 | 0 | |a Zhaoheng Liu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Number 2 Feibi Recipe Reduces PM2.5-Induced Lung Injury in Rats |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Air pollution is the main cause of respiratory diseases. Fine particulates with the diameter below 2.5 μm can get into the alveoli and then enter the blood circulation through the lung tissue ventilation function and cause multiple systemic diseases especially the respiratory diseases. This study investigated the pathological mechanism of the lungs injury in rats induced by PM2.5 and the effect and mechanism of the Chinese herbal medicine number 2 Feibi Recipe (number 2 FBR) on lungs injury. In this experiment, Wistar rats were used. Lungs injury was induced by PM2.5. Number 2 FBR was used to treat the rats. The result showed that number 2 FBR could improve the lung injury in the rats. Meanwhile, it significantly reduced pathological response and inflammatory mediators including interleukin-6 (IL-6), interleukin-13 (IL-13), interleukin-17 (IL17), monocyte chemotactic protein-1 (MCP-1), and transforming growth factor-α (TNF-α) and upregulated glutathione peroxidase (GSH-Px) in the PM2.5 induced lung injury in the rats. Collectively, number 2 FBR appears to attenuate the lungs injury in rats induced by PM2.5. | ||
| 653 | 0 | |a Other systems of medicine | |
| 700 | 0 | |a Wei Wang |e verfasserin |4 aut | |
| 700 | 0 | |a Fang Cao |e verfasserin |4 aut | |
| 700 | 0 | |a Shuo Liu |e verfasserin |4 aut | |
| 700 | 0 | |a Xinxin Zou |e verfasserin |4 aut | |
| 700 | 0 | |a Guodong Li |e verfasserin |4 aut | |
| 700 | 0 | |a Haojie Yang |e verfasserin |4 aut | |
| 700 | 0 | |a Yang Jiao |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Evidence-Based Complementary and Alternative Medicine |d Hindawi Limited, 2004 |g (2018) |w (DE-627)DOAJ000122912 |x 1741427X |7 nnns |
| 773 | 1 | 8 | |g year:2018 |
| 856 | 4 | 0 | |u https://doi.org/10.1155/2018/3674145 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/23c4c033745f474d93154fcc030d8464 |z kostenfrei |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1155/2018/3674145 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1741-427X |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1741-4288 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |j 2018 | ||